Cite
A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese.
MLA
Qi, Fuzhen, et al. “A Genetic Variant in the Promoter Region of MiR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese.” PLoS ONE, vol. 9, no. 1, Jan. 2014, pp. 1–5. EBSCOhost, https://doi.org/10.1371/journal.pone.0085394.
APA
Qi, F., Huang, M., Pan, Y., Liu, Y., Liu, J., Wen, J., Xie, K., Shen, H., Ma, H., Miao, Y., & Hu, Z. (2014). A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese. PLoS ONE, 9(1), 1–5. https://doi.org/10.1371/journal.pone.0085394
Chicago
Qi, Fuzhen, Mingde Huang, Yun Pan, Yao Liu, Jibin Liu, Juan Wen, Kaipeng Xie, et al. 2014. “A Genetic Variant in the Promoter Region of MiR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese.” PLoS ONE 9 (1): 1–5. doi:10.1371/journal.pone.0085394.